<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.2.269">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Comparative Effectiveness and Personalized Medicine Research Using Real-World Data - 4&nbsp; Systematic review and meta-analysis of Real-World Evidence</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
    color: #aaaaaa;
  }
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } /* Alert */
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } /* Annotation */
code span.at { color: #7d9029; } /* Attribute */
code span.bn { color: #40a070; } /* BaseN */
code span.bu { color: #008000; } /* BuiltIn */
code span.cf { color: #007020; font-weight: bold; } /* ControlFlow */
code span.ch { color: #4070a0; } /* Char */
code span.cn { color: #880000; } /* Constant */
code span.co { color: #60a0b0; font-style: italic; } /* Comment */
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } /* CommentVar */
code span.do { color: #ba2121; font-style: italic; } /* Documentation */
code span.dt { color: #902000; } /* DataType */
code span.dv { color: #40a070; } /* DecVal */
code span.er { color: #ff0000; font-weight: bold; } /* Error */
code span.ex { } /* Extension */
code span.fl { color: #40a070; } /* Float */
code span.fu { color: #06287e; } /* Function */
code span.im { color: #008000; font-weight: bold; } /* Import */
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } /* Information */
code span.kw { color: #007020; font-weight: bold; } /* Keyword */
code span.op { color: #666666; } /* Operator */
code span.ot { color: #007020; } /* Other */
code span.pp { color: #bc7a00; } /* Preprocessor */
code span.sc { color: #4070a0; } /* SpecialChar */
code span.ss { color: #bb6688; } /* SpecialString */
code span.st { color: #4070a0; } /* String */
code span.va { color: #19177c; } /* Variable */
code span.vs { color: #4070a0; } /* VerbatimString */
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } /* Warning */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./chapter_12.html" rel="next">
<link href="./chapter_07.html" rel="prev">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>

<script src="site_libs/kePrint-0.0.1/kePrint.js"></script>
<link href="site_libs/lightable-0.0.1/lightable.css" rel="stylesheet">

  <script src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-chtml-full.js" type="text/javascript"></script>

</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
    <div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Systematic review and meta-analysis of Real-World Evidence</span></h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Comparative Effectiveness and Personalized Medicine Research Using Real-World Data</a> 
    </div>
      </div>
      <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">Preface</a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./chapter_04.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Dealing with missing data</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./chapter_06.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Confounding adjustment using propensity score methods</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./chapter_07.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Effect Modification Analysis within the Propensity score Framework</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./chapter_10.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Systematic review and meta-analysis of Real-World Evidence</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./chapter_12.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Dealing with irregular and informative visits</span></a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">References</a>
  </div>
</li>
    </ul>
    </div>
</nav>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#introduction" id="toc-introduction" class="nav-link active" data-scroll-target="#introduction"><span class="toc-section-number">4.1</span>  Introduction</a></li>
  <li><a href="#advanced-therapies-for-ulcerative-colitis" id="toc-advanced-therapies-for-ulcerative-colitis" class="nav-link" data-scroll-target="#advanced-therapies-for-ulcerative-colitis"><span class="toc-section-number">4.2</span>  Advanced Therapies for Ulcerative Colitis</a>
  <ul class="collapse">
  <li><a href="#example-dataset" id="toc-example-dataset" class="nav-link" data-scroll-target="#example-dataset"><span class="toc-section-number">4.2.1</span>  Example Dataset</a></li>
  <li><a href="#network-meta-analysis" id="toc-network-meta-analysis" class="nav-link" data-scroll-target="#network-meta-analysis"><span class="toc-section-number">4.2.2</span>  Network meta-analysis</a></li>
  </ul></li>
  <li><a href="#covid-19" id="toc-covid-19" class="nav-link" data-scroll-target="#covid-19"><span class="toc-section-number">4.3</span>  COVID-19</a>
  <ul class="collapse">
  <li><a href="#example-dataset-1" id="toc-example-dataset-1" class="nav-link" data-scroll-target="#example-dataset-1"><span class="toc-section-number">4.3.1</span>  Example Dataset</a></li>
  <li><a href="#network-meta-analysis-1" id="toc-network-meta-analysis-1" class="nav-link" data-scroll-target="#network-meta-analysis-1"><span class="toc-section-number">4.3.2</span>  Network meta-analysis</a></li>
  </ul></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title d-none d-lg-block"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Systematic review and meta-analysis of Real-World Evidence</span></h1>
</div>


<div class="quarto-title-meta-author">
  <div class="quarto-title-meta-heading">Authors</div>
  <div class="quarto-title-meta-heading">Affiliations</div>
  
    <div class="quarto-title-meta-contents">
    Dimitris Mavridis 
  </div>
    <div class="quarto-title-meta-contents">
        <p class="affiliation">
            University of Ioannina
          </p>
      </div>
      <div class="quarto-title-meta-contents">
    Thomas Debray <a href="https://orcid.org/0000-0002-1790-2719" class="quarto-title-author-orcid"> <img src="data:image/png;base64,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"></a>
  </div>
    <div class="quarto-title-meta-contents">
        <p class="affiliation">
            Smart Data Analysis and Statistics B.V.
          </p>
      </div>
    </div>

<div class="quarto-title-meta">

      
  
    
  </div>
  

</header>

<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-1_ba531256ba5161c294d52b2c63cbe000">

</div>
<section id="introduction" class="level2" data-number="4.1">
<h2 data-number="4.1" class="anchored" data-anchor-id="introduction"><span class="header-section-number">4.1</span> Introduction</h2>
<p>We first load the required packages</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-2_687af4d7dc1ee383fa1bbf5d9274e104">
<div class="sourceCode cell-code" id="cb1"><pre class="sourceCode r code-with-copy"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(dplyr)</span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="fu">library</span>(netmeta)</span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
</div>
</section>
<section id="advanced-therapies-for-ulcerative-colitis" class="level2" data-number="4.2">
<h2 data-number="4.2" class="anchored" data-anchor-id="advanced-therapies-for-ulcerative-colitis"><span class="header-section-number">4.2</span> Advanced Therapies for Ulcerative Colitis</h2>
<p>In this example, we consider a systematic literature review of Phase 3 randomized controlled trials investigating the following advanced therapies: infliximab, adalimumab, vedolizumab, golimumab, tofacitinib, ustekinumab, filgotinib, ozanimod, and upadacitinib <span class="citation" data-cites="panaccione_efficacy_2023">(<a href="references.html#ref-panaccione_efficacy_2023" role="doc-biblioref">Panaccione et al. 2023</a>)</span>. This review included 48 RCTs, from which 23 were found eligible for inclusion in a network meta-analysis.</p>
<p>The included RCT populations were largely comparable in their baseline characteristics, though some heterogeneity was noted in weight, disease duration, extent of disease, and concomitant medications. A risk of bias assessment showed a low risk of bias for all included RCTs, which were all industry sponsored.</p>
<section id="example-dataset" class="level3" data-number="4.2.1">
<h3 data-number="4.2.1" class="anchored" data-anchor-id="example-dataset"><span class="header-section-number">4.2.1</span> Example Dataset</h3>
<p>We here focus on the synthesis of 18 trials that contributed efficacy data for induction in bio-naive populations. The following FDA- and/or EMA-approved biologic or SMD doses were investigated:</p>
<ul>
<li>Adalimumab subcutaneous 160 mg at week 0, 80 mg at week 2, and 40 mg at week 4 (<code>ADA160/80</code>)</li>
<li>Infliximab intravenous 5 mg/kg (<code>INF5</code>) at weeks 0, 2, and 6 then every 8 weeks</li>
<li>Infliximab intravenous 10 mg/kg (<code>INF10</code>) at weeks 0, 2, and 6 then every 8 weeks</li>
<li>Filgotinib oral 100 mg once daily (<code>FIL100</code>)</li>
<li>Filgotinib oral 200 mg once daily (<code>FIL200</code>)</li>
<li>Golimumab subcutaneous 200 mg at week 0 and 100 mg at week 2 (<code>GOL200/100</code>)</li>
<li>Ozanimod oral 0.23 mg once daily for 4 days, 0.46 mg once daily for 3 days, then 0.92 mg once daily (<code>OZA0.92</code>)</li>
<li>Tofacitinib oral 10 mg twice daily for 8 weeks (<code>TOF10</code>)</li>
<li>Upadacitinib oral 45 mg once daily for 8 weeks (<code>UPA45</code>)</li>
<li>Ustekinumab intravenous 6 mg/kg at week 0 (<code>UST6</code>)</li>
<li>Vedolizumab intravenous 300 mg at weeks 0, 2, and 6 (<code>VED300</code>)</li>
</ul>
<p>The reference treatment is placebo (<code>PBO</code>).</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-3_9c23db7041279ca4da9d5ed69c88f02c">
<div class="cell-output-display">

<table class="table" style="margin-left: auto; margin-right: auto;"><caption>Efficacy outcomes (i.e., clinical remission) data of induction bio-naïve populations</caption>
 <thead>
  <tr>
   <th style="text-align:left;"> studlab </th>
   <th style="text-align:right;"> treat1 </th>
   <th style="text-align:right;"> treat2 </th>
   <th style="text-align:right;"> event1 </th>
   <th style="text-align:right;"> n1 </th>
   <th style="text-align:right;"> event2 </th>
   <th style="text-align:right;"> n2 </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> ACT-1 </td>
   <td style="text-align:right;"> INF10 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> 39 </td>
   <td style="text-align:right;"> 122 </td>
   <td style="text-align:right;"> 47 </td>
   <td style="text-align:right;"> 121 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ACT-1 </td>
   <td style="text-align:right;"> INF10 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 39 </td>
   <td style="text-align:right;"> 122 </td>
   <td style="text-align:right;"> 18 </td>
   <td style="text-align:right;"> 121 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ACT-1 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 47 </td>
   <td style="text-align:right;"> 121 </td>
   <td style="text-align:right;"> 18 </td>
   <td style="text-align:right;"> 121 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ACT-2 </td>
   <td style="text-align:right;"> INF10 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> 33 </td>
   <td style="text-align:right;"> 120 </td>
   <td style="text-align:right;"> 41 </td>
   <td style="text-align:right;"> 121 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ACT-2 </td>
   <td style="text-align:right;"> INF10 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 33 </td>
   <td style="text-align:right;"> 120 </td>
   <td style="text-align:right;"> 7 </td>
   <td style="text-align:right;"> 123 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ACT-2 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 41 </td>
   <td style="text-align:right;"> 121 </td>
   <td style="text-align:right;"> 7 </td>
   <td style="text-align:right;"> 123 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> GEMINI 1 </td>
   <td style="text-align:right;"> VED300 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 30 </td>
   <td style="text-align:right;"> 130 </td>
   <td style="text-align:right;"> 5 </td>
   <td style="text-align:right;"> 76 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Japic CTI-060298 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 21 </td>
   <td style="text-align:right;"> 104 </td>
   <td style="text-align:right;"> 11 </td>
   <td style="text-align:right;"> 104 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Jiang 2015 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 22 </td>
   <td style="text-align:right;"> 41 </td>
   <td style="text-align:right;"> 9 </td>
   <td style="text-align:right;"> 41 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> M10-447 </td>
   <td style="text-align:right;"> ADA160/80 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 9 </td>
   <td style="text-align:right;"> 90 </td>
   <td style="text-align:right;"> 11 </td>
   <td style="text-align:right;"> 96 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> NCT01551290 </td>
   <td style="text-align:right;"> INF5 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 11 </td>
   <td style="text-align:right;"> 50 </td>
   <td style="text-align:right;"> 5 </td>
   <td style="text-align:right;"> 49 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> NCT02039505 </td>
   <td style="text-align:right;"> VED300 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 22 </td>
   <td style="text-align:right;"> 79 </td>
   <td style="text-align:right;"> 6 </td>
   <td style="text-align:right;"> 41 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> OCTAVE 1 </td>
   <td style="text-align:right;"> TOF10 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 56 </td>
   <td style="text-align:right;"> 222 </td>
   <td style="text-align:right;"> 9 </td>
   <td style="text-align:right;"> 57 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> OCTAVE 2 </td>
   <td style="text-align:right;"> TOF10 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 43 </td>
   <td style="text-align:right;"> 195 </td>
   <td style="text-align:right;"> 4 </td>
   <td style="text-align:right;"> 47 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> PURSUIT-SC </td>
   <td style="text-align:right;"> GOL200/100 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 45 </td>
   <td style="text-align:right;"> 253 </td>
   <td style="text-align:right;"> 16 </td>
   <td style="text-align:right;"> 251 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> SELECTION </td>
   <td style="text-align:right;"> FIL100 </td>
   <td style="text-align:right;"> FIL200 </td>
   <td style="text-align:right;"> 47 </td>
   <td style="text-align:right;"> 277 </td>
   <td style="text-align:right;"> 60 </td>
   <td style="text-align:right;"> 245 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> SELECTION </td>
   <td style="text-align:right;"> FIL100 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 47 </td>
   <td style="text-align:right;"> 277 </td>
   <td style="text-align:right;"> 17 </td>
   <td style="text-align:right;"> 137 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> SELECTION </td>
   <td style="text-align:right;"> FIL200 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 60 </td>
   <td style="text-align:right;"> 245 </td>
   <td style="text-align:right;"> 17 </td>
   <td style="text-align:right;"> 137 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> TRUE NORTH </td>
   <td style="text-align:right;"> OZA0.92 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 66 </td>
   <td style="text-align:right;"> 299 </td>
   <td style="text-align:right;"> 10 </td>
   <td style="text-align:right;"> 151 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> U-ACCOMPLISH </td>
   <td style="text-align:right;"> UPA45 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 54 </td>
   <td style="text-align:right;"> 166 </td>
   <td style="text-align:right;"> 3 </td>
   <td style="text-align:right;"> 81 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> U-ACHIEVE Study 2 </td>
   <td style="text-align:right;"> UPA45 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 41 </td>
   <td style="text-align:right;"> 145 </td>
   <td style="text-align:right;"> 4 </td>
   <td style="text-align:right;"> 72 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ULTRA-1 </td>
   <td style="text-align:right;"> ADA160/80 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 24 </td>
   <td style="text-align:right;"> 130 </td>
   <td style="text-align:right;"> 12 </td>
   <td style="text-align:right;"> 130 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> ULTRA-2 </td>
   <td style="text-align:right;"> ADA160/80 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 32 </td>
   <td style="text-align:right;"> 150 </td>
   <td style="text-align:right;"> 16 </td>
   <td style="text-align:right;"> 145 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> UNIFI </td>
   <td style="text-align:right;"> UST6 </td>
   <td style="text-align:right;"> PBO </td>
   <td style="text-align:right;"> 27 </td>
   <td style="text-align:right;"> 147 </td>
   <td style="text-align:right;"> 15 </td>
   <td style="text-align:right;"> 151 </td>
  </tr>
</tbody>
</table>

</div>
</div>
<p>The corresponding network is displayed below:</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-4_f0a92d7385e2bbc41332a55c7a54c96b">
<div class="cell-output-display">
<div class="quarto-figure quarto-figure-center">
<figure class="figure">
<p><img src="chapter_10_files/figure-html/unnamed-chunk-4-1.png" class="img-fluid figure-img" width="960"></p>
<p></p><figcaption class="figure-caption">Evidence network of 18 trials that contributed efficacy data for induction in bio-naive populations</figcaption><p></p>
</figure>
</div>
</div>
</div>
</section>
<section id="network-meta-analysis" class="level3" data-number="4.2.2">
<h3 data-number="4.2.2" class="anchored" data-anchor-id="network-meta-analysis"><span class="header-section-number">4.2.2</span> Network meta-analysis</h3>
<p>Below, we conduct a random effects network meta-analysis of the reported study effects (expressed as odds ratio) and consider placebo (<code>treat = "PBO"</code>) as the control treatment.</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-5_b14ff4ed37c822e51841370713a292d1">
<div class="sourceCode cell-code" id="cb2"><pre class="sourceCode r code-with-copy"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" aria-hidden="true" tabindex="-1"></a>NMA.uc <span class="ot">&lt;-</span> <span class="fu">netmeta</span>(<span class="at">TE =</span> TE, <span class="at">seTE =</span> seTE, <span class="at">treat1 =</span> treat1, <span class="at">treat2 =</span> treat2,</span>
<span id="cb2-2"><a href="#cb2-2" aria-hidden="true" tabindex="-1"></a>                  <span class="at">studlab =</span> studlab, <span class="at">data =</span> UlcerativeColitis, <span class="at">sm =</span> <span class="st">"OR"</span>, </span>
<span id="cb2-3"><a href="#cb2-3" aria-hidden="true" tabindex="-1"></a>                  <span class="at">ref =</span> <span class="st">"PBO"</span>, <span class="at">comb.random =</span> <span class="cn">TRUE</span>)</span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
</div>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-6_2bff19fe8eb4be9362ca97aca96fb111">
<div class="cell-output-display">
<p><img src="chapter_10_files/figure-html/unnamed-chunk-6-1.png" class="img-fluid" width="672"></p>
</div>
</div>
<p>All treatments except <code>FIL100</code> and <code>UST6</code> are significantly more efficacious than <code>PBO</code> at inducing clinical remission. We can now estimate the probabilities of each treatment being at each possible rank and the SUCRAs (Surface Under the Cumulative RAnking curve):</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-7_08d229dba331acce03815c91e7c5f5d4">
<div class="sourceCode cell-code" id="cb3"><pre class="sourceCode r code-with-copy"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" aria-hidden="true" tabindex="-1"></a>sucra.uc <span class="ot">&lt;-</span> <span class="fu">rankogram</span>(NMA.uc, <span class="at">nsim =</span> <span class="dv">100</span>, <span class="at">random =</span> <span class="cn">TRUE</span>, <span class="at">common =</span> <span class="cn">FALSE</span>, </span>
<span id="cb3-2"><a href="#cb3-2" aria-hidden="true" tabindex="-1"></a>                      <span class="at">small.values =</span> <span class="st">"undesirable"</span>)</span>
<span id="cb3-3"><a href="#cb3-3" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb3-4"><a href="#cb3-4" aria-hidden="true" tabindex="-1"></a><span class="co"># Exctract the SUCRA values</span></span>
<span id="cb3-5"><a href="#cb3-5" aria-hidden="true" tabindex="-1"></a>sucra.uc<span class="sc">$</span>ranking.random</span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
<div class="cell-output cell-output-stdout">
<pre><code> ADA160/80     FIL100     FIL200 GOL200/100      INF10       INF5    OZA0.92 
0.28818182 0.18363636 0.45909091 0.61727273 0.58181818 0.75727273 0.73000000 
       PBO      TOF10      UPA45       UST6     VED300 
0.01545455 0.37000000 0.98181818 0.36636364 0.64909091 </code></pre>
</div>
</div>
<p>These results indicate that 98.2% of evaluated treatments are worse than <code>UPA45</code>.</p>
</section>
</section>
<section id="covid-19" class="level2" data-number="4.3">
<h2 data-number="4.3" class="anchored" data-anchor-id="covid-19"><span class="header-section-number">4.3</span> COVID-19</h2>
<section id="example-dataset-1" class="level3" data-number="4.3.1">
<h3 data-number="4.3.1" class="anchored" data-anchor-id="example-dataset-1"><span class="header-section-number">4.3.1</span> Example Dataset</h3>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-8_85909eebf794f09e56bb5bcc7c37181b">

</div>
<p>We have the following treatments: standard care (<code>treat = "STD"</code>), …</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-9_fe6398e09b440d4d7dfec31394a5f2f4">
<div class="cell-output-display">

<table class="table" style="margin-left: auto; margin-right: auto;">
 <thead>
  <tr>
   <th style="text-align:left;"> studlab </th>
   <th style="text-align:right;"> treat1 </th>
   <th style="text-align:right;"> treat2 </th>
   <th style="text-align:right;"> event1 </th>
   <th style="text-align:right;"> n1 </th>
   <th style="text-align:right;"> event2 </th>
   <th style="text-align:right;"> n2 </th>
  </tr>
 </thead>
<tbody>
  <tr>
   <td style="text-align:left;"> Abd-Elsalam et al </td>
   <td style="text-align:right;"> HCQ </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 6 </td>
   <td style="text-align:right;"> 97 </td>
   <td style="text-align:right;"> 5 </td>
   <td style="text-align:right;"> 97 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Biegel et al </td>
   <td style="text-align:right;"> REM </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 59 </td>
   <td style="text-align:right;"> 541 </td>
   <td style="text-align:right;"> 77 </td>
   <td style="text-align:right;"> 521 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Cao et al </td>
   <td style="text-align:right;"> LOP+RIT </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 19 </td>
   <td style="text-align:right;"> 99 </td>
   <td style="text-align:right;"> 25 </td>
   <td style="text-align:right;"> 100 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Cavalcanti et al </td>
   <td style="text-align:right;"> HCQ </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 1 </td>
   <td style="text-align:right;"> 221 </td>
   <td style="text-align:right;"> 1 </td>
   <td style="text-align:right;"> 227 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Davoudi-Monfared </td>
   <td style="text-align:right;"> INT-B </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 8 </td>
   <td style="text-align:right;"> 42 </td>
   <td style="text-align:right;"> 15 </td>
   <td style="text-align:right;"> 39 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Hermine et al </td>
   <td style="text-align:right;"> TOCI </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 7 </td>
   <td style="text-align:right;"> 63 </td>
   <td style="text-align:right;"> 8 </td>
   <td style="text-align:right;"> 67 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Horby et al </td>
   <td style="text-align:right;"> DEXA </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 482 </td>
   <td style="text-align:right;"> 2104 </td>
   <td style="text-align:right;"> 1110 </td>
   <td style="text-align:right;"> 4321 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Lyngbakken et al </td>
   <td style="text-align:right;"> HCQ </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 1 </td>
   <td style="text-align:right;"> 27 </td>
   <td style="text-align:right;"> 1 </td>
   <td style="text-align:right;"> 26 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Recovery group </td>
   <td style="text-align:right;"> LOP+RIT </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 374 </td>
   <td style="text-align:right;"> 1616 </td>
   <td style="text-align:right;"> 767 </td>
   <td style="text-align:right;"> 3424 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Rohmani </td>
   <td style="text-align:right;"> INT-B </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 2 </td>
   <td style="text-align:right;"> 33 </td>
   <td style="text-align:right;"> 6 </td>
   <td style="text-align:right;"> 33 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Rosas et al </td>
   <td style="text-align:right;"> TOCI </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 58 </td>
   <td style="text-align:right;"> 294 </td>
   <td style="text-align:right;"> 28 </td>
   <td style="text-align:right;"> 144 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Salama et al </td>
   <td style="text-align:right;"> TOCI </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 26 </td>
   <td style="text-align:right;"> 249 </td>
   <td style="text-align:right;"> 11 </td>
   <td style="text-align:right;"> 128 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Salvarini et al </td>
   <td style="text-align:right;"> TOCI </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 2 </td>
   <td style="text-align:right;"> 60 </td>
   <td style="text-align:right;"> 1 </td>
   <td style="text-align:right;"> 66 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Solidarity trial-LR </td>
   <td style="text-align:right;"> LOP+RIT </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 148 </td>
   <td style="text-align:right;"> 1399 </td>
   <td style="text-align:right;"> 146 </td>
   <td style="text-align:right;"> 1372 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Solidarity trial - HCQ </td>
   <td style="text-align:right;"> HCQ </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 104 </td>
   <td style="text-align:right;"> 947 </td>
   <td style="text-align:right;"> 84 </td>
   <td style="text-align:right;"> 906 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Solidarity trial - Interferon </td>
   <td style="text-align:right;"> INT-B </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 243 </td>
   <td style="text-align:right;"> 2050 </td>
   <td style="text-align:right;"> 216 </td>
   <td style="text-align:right;"> 2050 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Solidarity trial - Remdesivir </td>
   <td style="text-align:right;"> REM </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 301 </td>
   <td style="text-align:right;"> 2743 </td>
   <td style="text-align:right;"> 303 </td>
   <td style="text-align:right;"> 2708 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Spinner et al </td>
   <td style="text-align:right;"> REM </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 5 </td>
   <td style="text-align:right;"> 396 </td>
   <td style="text-align:right;"> 4 </td>
   <td style="text-align:right;"> 200 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Stone et al </td>
   <td style="text-align:right;"> TOCI </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 9 </td>
   <td style="text-align:right;"> 161 </td>
   <td style="text-align:right;"> 3 </td>
   <td style="text-align:right;"> 82 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Tomazini et al </td>
   <td style="text-align:right;"> DEXA </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 85 </td>
   <td style="text-align:right;"> 151 </td>
   <td style="text-align:right;"> 91 </td>
   <td style="text-align:right;"> 148 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Ulrich et al </td>
   <td style="text-align:right;"> HCQ </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 13 </td>
   <td style="text-align:right;"> 67 </td>
   <td style="text-align:right;"> 6 </td>
   <td style="text-align:right;"> 61 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Veiga et al </td>
   <td style="text-align:right;"> TOCI </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 14 </td>
   <td style="text-align:right;"> 65 </td>
   <td style="text-align:right;"> 6 </td>
   <td style="text-align:right;"> 64 </td>
  </tr>
  <tr>
   <td style="text-align:left;"> Wang et al </td>
   <td style="text-align:right;"> REM </td>
   <td style="text-align:right;"> STD </td>
   <td style="text-align:right;"> 22 </td>
   <td style="text-align:right;"> 158 </td>
   <td style="text-align:right;"> 10 </td>
   <td style="text-align:right;"> 78 </td>
  </tr>
</tbody>
</table>

</div>
</div>
</section>
<section id="network-meta-analysis-1" class="level3" data-number="4.3.2">
<h3 data-number="4.3.2" class="anchored" data-anchor-id="network-meta-analysis-1"><span class="header-section-number">4.3.2</span> Network meta-analysis</h3>
<p>Below, we conduct a random effects network meta-analysis where we consider standard care (<code>treat = "STD"</code>) as the control treatment.</p>
<div class="cell" data-hash="chapter_10_cache/html/unnamed-chunk-10_192eae6eb8c9553baa2da05ab618fd72">
<div class="sourceCode cell-code" id="cb5"><pre class="sourceCode r code-with-copy"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" aria-hidden="true" tabindex="-1"></a>NMA.covid <span class="ot">&lt;-</span> <span class="fu">netmeta</span>(<span class="at">TE =</span> TE, <span class="at">seTE =</span> seTE, <span class="at">treat1 =</span> treat1, <span class="at">treat2 =</span> treat2,</span>
<span id="cb5-2"><a href="#cb5-2" aria-hidden="true" tabindex="-1"></a>                     <span class="at">studlab =</span> studlab, <span class="at">data =</span> covid, <span class="at">sm =</span> <span class="st">"OR"</span>, <span class="at">ref =</span> <span class="st">"STD"</span>,</span>
<span id="cb5-3"><a href="#cb5-3" aria-hidden="true" tabindex="-1"></a>                     <span class="at">comb.random =</span> <span class="cn">TRUE</span>)</span>
<span id="cb5-4"><a href="#cb5-4" aria-hidden="true" tabindex="-1"></a><span class="fu">summary</span>(NMA.covid)</span></code><button title="Copy to Clipboard" class="code-copy-button"><i class="bi"></i></button></pre></div>
<div class="cell-output cell-output-stdout">
<pre><code>Original data:

                               treat1 treat2      TE   seTE
Abd-Elsalam et al                 HCQ    STD  0.1933 0.6233
Biegel et al                      REM    STD -0.3484 0.1851
Cao et al                     LOP+RIT    STD -0.3390 0.3442
Cavalcanti et al                  HCQ    STD  0.0269 1.4174
Davoudi-Monfared                INT-B    STD -0.9769 0.5126
Hermine et al                     STD   TOCI  0.0813 0.5501
Horby et al                      DEXA    STD -0.1512 0.0625
Lyngbakken et al                  HCQ    STD -0.0392 1.4417
Recovery group                LOP+RIT    STD  0.0422 0.0718
Rohmani                         INT-B    STD -1.2368 0.8579
Rosas et al                       STD   TOCI -0.0180 0.2565
Salama et al                      STD   TOCI -0.2152 0.3774
Salvarini et al                   STD   TOCI -0.8071 1.2380
Solidarity trial-LR           LOP+RIT    STD -0.0066 0.1234
Solidarity trial - HCQ            HCQ    STD  0.1883 0.1547
Solidarity trial - Interferon   INT-B    STD  0.1326 0.0992
Solidarity trial - Remdesivir     REM    STD -0.0219 0.0863
Spinner et al                     REM    STD -0.4674 0.6765
Stone et al                       STD   TOCI -0.4442 0.6809
Tomazini et al                   DEXA    STD -0.2148 0.2355
Ulrich et al                      HCQ    STD  0.7915 0.5294
Veiga et al                       STD   TOCI -0.9759 0.5244
Wang et al                        REM    STD  0.0953 0.4093

Number of treatment arms (by study):
                              narms
Abd-Elsalam et al                 2
Biegel et al                      2
Cao et al                         2
Cavalcanti et al                  2
Davoudi-Monfared                  2
Hermine et al                     2
Horby et al                       2
Lyngbakken et al                  2
Recovery group                    2
Rohmani                           2
Rosas et al                       2
Salama et al                      2
Salvarini et al                   2
Solidarity trial-LR               2
Solidarity trial - HCQ            2
Solidarity trial - Interferon     2
Solidarity trial - Remdesivir     2
Spinner et al                     2
Stone et al                       2
Tomazini et al                    2
Ulrich et al                      2
Veiga et al                       2
Wang et al                        2

Results (common effects model):

                               treat1 treat2     OR           95%-CI    Q
Abd-Elsalam et al                 HCQ    STD 1.2570 [0.9498; 1.6635] 0.00
Biegel et al                      REM    STD 0.9240 [0.7956; 1.0732] 2.12
Cao et al                     LOP+RIT    STD 1.0184 [0.9035; 1.1480] 1.08
Cavalcanti et al                  HCQ    STD 1.2570 [0.9498; 1.6635] 0.02
Davoudi-Monfared                INT-B    STD 1.0786 [0.8922; 1.3039] 4.22
Hermine et al                     STD   TOCI 0.8147 [0.5761; 1.1523] 0.27
Horby et al                      DEXA    STD 0.8560 [0.7605; 0.9636] 0.00
Lyngbakken et al                  HCQ    STD 1.2570 [0.9498; 1.6635] 0.03
Recovery group                LOP+RIT    STD 1.0184 [0.9035; 1.1480] 0.11
Rohmani                         INT-B    STD 1.0786 [0.8922; 1.3039] 2.34
Rosas et al                       STD   TOCI 0.8147 [0.5761; 1.1523] 0.53
Salama et al                      STD   TOCI 0.8147 [0.5761; 1.1523] 0.00
Salvarini et al                   STD   TOCI 0.8147 [0.5761; 1.1523] 0.24
Solidarity trial-LR           LOP+RIT    STD 1.0184 [0.9035; 1.1480] 0.04
Solidarity trial - HCQ            HCQ    STD 1.2570 [0.9498; 1.6635] 0.07
Solidarity trial - Interferon   INT-B    STD 1.0786 [0.8922; 1.3039] 0.33
Solidarity trial - Remdesivir     REM    STD 0.9240 [0.7956; 1.0732] 0.44
Spinner et al                     REM    STD 0.9240 [0.7956; 1.0732] 0.33
Stone et al                       STD   TOCI 0.8147 [0.5761; 1.1523] 0.12
Tomazini et al                   DEXA    STD 0.8560 [0.7605; 0.9636] 0.06
Ulrich et al                      HCQ    STD 1.2570 [0.9498; 1.6635] 1.13
Veiga et al                       STD   TOCI 0.8147 [0.5761; 1.1523] 2.16
Wang et al                        REM    STD 0.9240 [0.7956; 1.0732] 0.18
                              leverage
Abd-Elsalam et al                 0.05
Biegel et al                      0.17
Cao et al                         0.03
Cavalcanti et al                  0.01
Davoudi-Monfared                  0.04
Hermine et al                     0.10
Horby et al                       0.93
Lyngbakken et al                  0.01
Recovery group                    0.72
Rohmani                           0.01
Rosas et al                       0.48
Salama et al                      0.22
Salvarini et al                   0.02
Solidarity trial-LR               0.25
Solidarity trial - HCQ            0.85
Solidarity trial - Interferon     0.95
Solidarity trial - Remdesivir     0.78
Spinner et al                     0.01
Stone et al                       0.07
Tomazini et al                    0.07
Ulrich et al                      0.07
Veiga et al                       0.11
Wang et al                        0.03

Results (random effects model):

                               treat1 treat2     OR           95%-CI
Abd-Elsalam et al                 HCQ    STD 1.2570 [0.9498; 1.6635]
Biegel et al                      REM    STD 0.9240 [0.7956; 1.0732]
Cao et al                     LOP+RIT    STD 1.0184 [0.9035; 1.1480]
Cavalcanti et al                  HCQ    STD 1.2570 [0.9498; 1.6635]
Davoudi-Monfared                INT-B    STD 1.0786 [0.8922; 1.3039]
Hermine et al                     STD   TOCI 0.8147 [0.5761; 1.1523]
Horby et al                      DEXA    STD 0.8560 [0.7605; 0.9636]
Lyngbakken et al                  HCQ    STD 1.2570 [0.9498; 1.6635]
Recovery group                LOP+RIT    STD 1.0184 [0.9035; 1.1480]
Rohmani                         INT-B    STD 1.0786 [0.8922; 1.3039]
Rosas et al                       STD   TOCI 0.8147 [0.5761; 1.1523]
Salama et al                      STD   TOCI 0.8147 [0.5761; 1.1523]
Salvarini et al                   STD   TOCI 0.8147 [0.5761; 1.1523]
Solidarity trial-LR           LOP+RIT    STD 1.0184 [0.9035; 1.1480]
Solidarity trial - HCQ            HCQ    STD 1.2570 [0.9498; 1.6635]
Solidarity trial - Interferon   INT-B    STD 1.0786 [0.8922; 1.3039]
Solidarity trial - Remdesivir     REM    STD 0.9240 [0.7956; 1.0732]
Spinner et al                     REM    STD 0.9240 [0.7956; 1.0732]
Stone et al                       STD   TOCI 0.8147 [0.5761; 1.1523]
Tomazini et al                   DEXA    STD 0.8560 [0.7605; 0.9636]
Ulrich et al                      HCQ    STD 1.2570 [0.9498; 1.6635]
Veiga et al                       STD   TOCI 0.8147 [0.5761; 1.1523]
Wang et al                        REM    STD 0.9240 [0.7956; 1.0732]

Number of studies: k = 23
Number of pairwise comparisons: m = 23
Number of treatments: n = 7
Number of designs: d = 6

Common effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'STD'):
            OR           95%-CI     z p-value
DEXA    0.8560 [0.7605; 0.9636] -2.57  0.0101
HCQ     1.2570 [0.9498; 1.6635]  1.60  0.1097
INT-B   1.0786 [0.8922; 1.3039]  0.78  0.4346
LOP+RIT 1.0184 [0.9035; 1.1480]  0.30  0.7649
REM     0.9240 [0.7956; 1.0732] -1.04  0.3006
STD          .                .     .       .
TOCI    1.2274 [0.8678; 1.7359]  1.16  0.2467

Random effects model

Treatment estimate (sm = 'OR', comparison: other treatments vs 'STD'):
            OR           95%-CI     z p-value
DEXA    0.8560 [0.7605; 0.9636] -2.57  0.0101
HCQ     1.2570 [0.9498; 1.6635]  1.60  0.1097
INT-B   1.0786 [0.8922; 1.3039]  0.78  0.4346
LOP+RIT 1.0184 [0.9035; 1.1480]  0.30  0.7649
REM     0.9240 [0.7956; 1.0732] -1.04  0.3006
STD          .                .     .       .
TOCI    1.2274 [0.8678; 1.7359]  1.16  0.2467

Quantifying heterogeneity / inconsistency:
tau^2 = 0; tau = 0; I^2 = 0% [0.0%; 50.0%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                    Q d.f. p-value
Total           15.83   17  0.5358
Within designs  15.83   17  0.5358
Between designs  0.00    0      --</code></pre>
</div>
</div>


<div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography" style="display: none">
<div id="ref-panaccione_efficacy_2023" class="csl-entry" role="doc-biblioentry">
Panaccione, Remo, Eric B Collins, Gil Y Melmed, Severine Vermeire, Silvio Danese, Peter D R Higgins, Christina S Kwon, et al. 2023. <span>“Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-Analysis.”</span> <em>Crohn<span></span>s <span>&amp;</span>Amp<span class="math inline">\(\mathsemicolon\)</span> Colitis 360</em> 5 (2). <a href="https://doi.org/10.1093/crocol/otad009">https://doi.org/10.1093/crocol/otad009</a>.
</div>
</div>
</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./chapter_07.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Effect Modification Analysis within the Propensity score Framework</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./chapter_12.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Dealing with irregular and informative visits</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->



</body></html>